Hypoxia-Induced Epithelial-Mesenchymal Transition Is Involved in Bleomycin-Induced Lung Fibrosis
Pulmonary fibrosis is a severe disease that contributes to the morbidity and mortality of a number of lung diseases. However, the molecular and cellular mechanisms leading to lung fibrosis are poorly understood. This study investigated the roles of epithelial-mesenchymal transition (EMT) and the ass...
Main Authors: | Guo, Liang, Xu, Jun-mei, Liu, Lei, Liu, Su-mei, Zhu, Rong |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706863/ |
Similar Items
-
2-aminopurine suppresses the TGF-β1-induced epithelial–mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis
by: Dong Weng, et al.
Published: (2018-02-01) -
Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis
by: Lan, Ying-Wei, et al.
Published: (2015) -
Melatonin Inhibits Endoplasmic Reticulum Stress and Epithelial-Mesenchymal Transition during Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Zhao, Hui, et al.
Published: (2014) -
Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
by: Chen, Y-L, et al.
Published: (2013) -
Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation
by: Guan, Ruijuan, et al.
Published: (2016)